A Cochrane Collaboration systematic review of 32 clinical trials involving nearly 75,000 elderly women, concludes that daily supplementation with vitamin D3 (cholecalciferol), significantly decrease all-cause mortality.
In the past decade, researchers on neuroanatomy and neurotransmitters have found links between genes, the brain, and addiction behavior. What we now know about the dopamine reward circuits in the brain is helping addiction specialists to create effective holistic approaches to addiction recovery.
Bone mineral density is just one part of the physiological equation that adds up to bone health. Bone flexibility, a reflection of the collagen content in a person’s bone, is equally important but usually overlooked. Vitamin K can help.
At
a dose of 1,200 IU per day, vitamin D3 reduced the incidence of Influenza A among a cohort of Japanese schoolchildren, but was associated with an increase in incidence of Influenza B, giving no overall advantage in preventing flu-associated illness.
Severe joint pain is a common side-effect of tamoxifen therapy for breast cancer, and it is associated with vitamin D deficiency. Supplementation aimed at pushing serum vitamin D levels over 40 ng/ml can prevent or attenuate the pain.
Calorie restriction—by as much as 50%-70% of normal intake—is the only intervention consistently proven to extend lifespan. But that’s not a realistic treatment option for most people. Fortunately, natural substances including resveratrol, carnosine, and carnitine can mimic the beneficial effects of calorie restriction.
Despite the Institute of Medicine's recent report, many nutrition-minded oncologists believe high-dose vitamin D supplementation—upwards of 4,000 IU/day—has potential to markedly reduce risk of primary breast cancer as well as breast cancer recurrence, with minimal risk of toxicity.
The Institute of Medicine’s Nov. 30 consensus statement claiming most Americans do not need supplemental vitamin D—a position that runs counter to the views of many clinicians and researchers⎯has some folks wondering if committee members had preexisting biases or vested interests against supplementation.
It turns out that at least two members of the committee hold patents on synthetic vitamin D analogs in development or already on the market as prescription drugs, and significant relationships with companies involved in vitamin D drug development.
Copyright © 2019 Holistic Primary Care. All Rights Reserved.
